Left Atrial Appendage Occlusion for AF Patients Unable to Use Oral Anticoagulation Therapy
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 609 participants.
Also called NCT04676880
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 609 participants
- Registry
-
NCT04676880
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Netherlands
- Registry status
- Unknown status
Technical summary
Registry record NCT04676880. Randomized; no masking; primary purpose prevention. Start 2021-01-01 (actual); primary completion 2026-05-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Left Atrial Appendage Occlusion for AF Patients Unable to Use Oral Anticoagulation Therapy
- Acronym
- COMPARE-LAAO
- Condition
- Atrial Fibrillation
- Condition
- Anticoagulants and Bleeding Disorders
- Intervention (Device)
- Left atrial appendage occlusion (Watchman FLX or Amplatzer Amulet)
- Lead sponsor
- R&D Cardiologie
- Collaborator
- ZonMw: The Netherlands Organisation for Health Research and Development
Record details
- Record id
cardio:ct-nct04676880- Content hash
69bdf21058f482dce5659aab6c694d9c8fbd64ad8ab636746019603db73240aa